Skip to Main Content

Children and teenagers with severe, sometimes life-threatening peanut allergies can reduce their risk from accidental exposure with a new treatment approved Friday by the Food and Drug Administration.

But administering the new treatment, called Palforzia and made by Aimmune Therapeutics (AIMT), is cumbersome and carries its own safety risks, which may deter families and allergists from using it.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

  • Adam what do you think of Dbvt’s patch? They have used reactive dose(Eliciting dose) in their trial rather than tolerable dose and seems to be in effort to hide true efficacy.

Comments are closed.